FDA Holds Public Hearing on Psychedelic Drugs
The US Food and Drug Administration held a public hearing to gather feedback on the therapeutic use of psychedelics. The move supports the administration push to speed up treatments for mental illnesses.
Xurve View
Insights:
Xurve View
The United States Food and Drug Administration will hold a public hearing on Monday to gather feedback on psychedelic drug development. The hearing marks the latest milestone in an administration-led push to accelerate treatments for mental illnesses. The initiative could reshape clinical trials and speed up commercial pathways for developers.
